IL20RB antisense RNA 1 (IL20RB-AS1)

“IL20RB antisense RNA 1” (IL20RB-AS1) is annotated as a long non-coding RNA (lncRNA) transcribed antisense to the interleukin-20 receptor subunit beta (IL20RB) gene. It is not a protein, receptor, enzyme, or canonical therapeutic target. There is currently very limited information on its biological function, molecular interactions, involvement in signaling pathways, or disease roles in the scientific literature. Most research on IL20RB and the interleukin-20 receptor complex pertains to the protein-coding gene (IL20RB), not to the antisense RNA. **Note:** If you intended the protein/receptor “interleukin-20 receptor subunit beta” (IL20RB), that is a well-characterized cell-surface cytokine receptor subunit. However, “IL20RB-AS1” is a different, poorly characterized non-coding RNA and does **not** fit the usual definitions of a druggable therapeutic target[1][2][3]. - IL20RB-AS1 as such is not classified as a receptor, enzyme, transporter, or direct therapeutic target. - There is no evidence of drugs, biomarkers, or safety data for IL20RB-AS1. **Correction:** If your query was in fact meant for “interleukin-20 receptor subunit beta” (IL20RB), please specify, since all major resources and literature focus on that target for therapeutic applications, not IL20RB-AS1.

Other names

IL20RB-AS1Interleukin 20 receptor subunit beta antisense RNA 1 (potential)lncRNA IL20RB-AS1